WHO Grade III Glioma
Showing 1 - 10 of 10
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
- +3 more
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 21, 2022
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of
Recruiting
- Diffuse Midline Glioma (DMG)
- +7 more
- ONC206
- Standard of Care Radiation Therapy
-
San Francisco, California
- +2 more
Sep 13, 2022
Glioblastoma, Recurrent Adult Brain Tumor, Malignant Glioma Trial in Richmond (sorafenib tosylate, valproic acid, sildenafil
Active, not recruiting
- Glioblastoma
- +3 more
- sorafenib tosylate
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Mar 21, 2022
Glioblastoma, Low Grade Glioma, Malignant Glioma Trial in Houston (Mind-Body Intervention Procedure, Quality-of-Life Assessment,
Completed
- Glioblastoma
- +5 more
- Mind-Body Intervention Procedure
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 8, 2021
Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Philadelphia (Intensity-Modulated Radiation Therapy,
Recruiting
- Glioblastoma
- +2 more
- Intensity-Modulated Radiation Therapy
- Quality-of-Life
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021
Glioblastoma, Malignant Glioma, WHO Grade III Glioma Trial in Scottsdale (Palliative Therapy, Quality-of-Life Assessment,
Completed
- Glioblastoma
- +2 more
- Palliative Therapy
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Nov 24, 2020
Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Houston (Educational Intervention, Questionnaire
Recruiting
- Glioblastoma
- +2 more
- Educational Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 20, 2020